Treatment cohorts
| Cohort no. . | BST-236 dose . | No. of patients per protocol . |
|---|---|---|
| 1 | Age <50 y: 0.5 g/m2 per d | 1 patient |
| Age ≥50 y: 0.3 g/m2 per d | 2 patients | |
| 2 | Age <50 y: 1.5 g/m2 per d | 0 patients |
| Age ≥50 y: 0.8 g/m2 per d | 3 patients (1 patient received 2 induction courses) | |
| 3 | Age <50 y: 3 g/m2 per d | 0 patients |
| Age ≥50 y: 1.5 g/m2 per d | 4 patients (1 patient discontinued on day 2) | |
| 4 | Age <50 y: 4.5 g/m2 per d | 1 patient |
| Age ≥50 y: 2.3 g/m2 per d | 5 patients | |
| 5 | 4.5 g/m2 per d (no age limit) | 3 patients |
| 6 | 6 g/m2 per d (no age limit) | 7 patients (1 patient discontinued on day 2; 1 patient discontinued on day 3; 1 patient received 2 induction courses) |
| Total | 26 |
| Cohort no. . | BST-236 dose . | No. of patients per protocol . |
|---|---|---|
| 1 | Age <50 y: 0.5 g/m2 per d | 1 patient |
| Age ≥50 y: 0.3 g/m2 per d | 2 patients | |
| 2 | Age <50 y: 1.5 g/m2 per d | 0 patients |
| Age ≥50 y: 0.8 g/m2 per d | 3 patients (1 patient received 2 induction courses) | |
| 3 | Age <50 y: 3 g/m2 per d | 0 patients |
| Age ≥50 y: 1.5 g/m2 per d | 4 patients (1 patient discontinued on day 2) | |
| 4 | Age <50 y: 4.5 g/m2 per d | 1 patient |
| Age ≥50 y: 2.3 g/m2 per d | 5 patients | |
| 5 | 4.5 g/m2 per d (no age limit) | 3 patients |
| 6 | 6 g/m2 per d (no age limit) | 7 patients (1 patient discontinued on day 2; 1 patient discontinued on day 3; 1 patient received 2 induction courses) |
| Total | 26 |